Ispire Technology (ISPR) Q3 2025 earnings summary

Executive summary

• Q3 FY2025 revenue was $26.2M, down 12.7% year-over-year, mainly due to lower vaping product sales in North America and Asia Pacific.

• Net loss for Q3 FY2025 was $10.9M ($0.19/share), compared to $5.9M ($0.11/share) in the prior year; nine-month net loss was $24.5M ($0.43/share), up from $11.3M ($0.21/share).

• Gross margin for Q3 FY2025 declined to 18.2% from 20.4% year-over-year; nine-month gross margin improved to 18.8% from 16.8%.

• Accounts receivable decreased to $60.4M from $67.7M, reflecting a focus on higher-quality customers.

• Manufacturing transition to Malaysia is expected to reduce annual operating expenses by $8M and mitigate tariff risks.

Financial highlights

• Q3 FY2025 revenue: $26.2M (down 12.7% YoY); nine months: $107.4M (down 6.3% YoY).

• Q3 FY2025 gross profit: $4.8M (down from $6.1M); nine months: $20.2M (up from $19.2M).

• Q3 FY2025 operating expenses: $15.4M (up from $11.8M); nine months: $43.4M (up from $29.7M).

• Cash and equivalents at March 31, 2025: $23.5M; working capital was negative $2.1M.

• Net cash used in operations (nine months): $12.1M, improved from $16.9M last year.

Outlook and guidance

• Management expects current cash, future operating cash flows, and a $20M loan to be sufficient for working capital needs over the next 12 months.

• Anticipates final approval for a federal nicotine manufacturing license in Malaysia in the coming months, enabling full-scale production.

• Restructuring and manufacturing shift to Malaysia expected to reduce costs and improve financial stability.

• Focus remains on margin expansion, revenue generation, and further accounts receivable reduction.

• Additional financing may be required if adverse conditions or accelerated growth occur.